Cearvol Diamond X1 vs Yeasound RIC700

The Cearvol Diamond X1 is a budget-priced OTC hearing aid that earned a B grade with a SoundScore of 3.7/5 in our lab testing, placing it in the top 45% of OTC devices. At $199, it represents an accessible entry point for those exploring hearing amplification. The Diamond X1's standout performance is in music streaming, scoring 4.1/5—a strong result that sits 2.18 points above the OTC category average. This makes it notably capable for users who prioritize audio entertainment through their hearing devices. Feedback handling is also excellent at 4.5/5, meaning users should experience minimal whistling during normal use. However, speech performance presents limitations. Speech in quiet scores a mixed 2.8/5, and speech in noise registers at 1.7/5. While both metrics technically sit above category averages (+0.03 and +0.22 points respectively), they remain low in absolute terms—important context for anyone prioritizing conversation clarity. Own-voice comfort is another weakness, scoring 1.7/5, which is 0.81 points below the category average and may affect how natural users sound to themselves. The Diamond X1 is best suited for budget-conscious consumers who value music streaming quality and aren't heavily reliant on challenging listening environments. Those who prioritize speech understanding in noise or natural own-voice perception may want to consider alternatives in this price range, such as the higher-scoring Elehear Beyond or Apple AirPods Pro 2.

The Yeasound RIC700 is a budget-priced OTC hearing aid that delivers A-grade performance in HearAdvisor's lab testing, placing it in the top 14% of the 65 OTC devices we've evaluated. At $399, it offers strong value for consumers seeking quality amplification without prescription-level costs. In our testing, the RIC700 excels at speech clarity in quiet environments, scoring 4.2/5—a strong result that sits 1.41 points above the OTC category average. Speech understanding in noisy settings scores 1.9/5, which is above the category average but remains low in absolute terms, a common limitation across OTC devices. Music streaming quality reaches 2.9/5, nearly a full point above the category average, though still mixed overall. Feedback handling is excellent at 4.6/5. The device does show some limitations. Own-voice comfort scores 2.0/5, falling 0.51 points below the category average—users may notice some occlusion effects when speaking. This behind-the-ear style features rechargeable batteries and supports both iPhone and Android streaming with hands-free capability. The RIC700 competes well within its price bracket, though shoppers should note that the higher-ranked Yeasound RIC800 and Sony CRE-E10 are available at similar price points with stronger overall scores. For budget-conscious consumers prioritizing speech clarity in quieter listening situations, the RIC700 represents a solid option in the OTC market.